Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.00
-0.35 (-1.91%)
At close: May 14, 2026
Market Cap14.50B +54.4%
Revenue (ttm)2.02B +39.0%
Net Income337.22M +39.0%
EPS0.42 -8.6%
Shares Out810.02M
PE Ratio43.00
Forward PE23.71
Dividend0.70 (3.88%)
Ex-Dividend DateNov 24, 2025
Volume1,706,348
Average Volume2,385,827
Open18.35
Previous Close18.35
Day's Range18.00 - 18.40
52-Week Range15.40 - 40.10
Betan/a
RSI35.37
Earnings DateMay 15, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd. [Read more]

Founded 2018
Employees 20
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 7780
Full Company Profile

Financial Performance

In 2025, Daiken Biomedical's revenue was 1.90 billion, an increase of 39.10% compared to the previous year's 1.36 billion. Earnings were 337.87 million, an increase of 217.01%.

Financial Statements